EDF announces the signature of a €6 billion syndicated credit facility indexed to ESG indicators On 29 November 2024, EDF (BBB positive S&P / Baa1 stable Moody's / BBB+ negative Fitch) signed a €6 bil ...

Future Vision II Acquisition Corp., (NASDAQ: FVNNU) a publicly traded special purpose acquisition company (the "Future Vision") and Viwo Technology Inc., a ...

High Arctic Overseas Holdings Corp. (TSXV: HOH) ("High Arctic Overseas" or the "Corporation") has released its first quarterly financial and operating ...

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage ...

Greenbrook TMS Inc. (OTCQB: GBNHF) ("Greenbrook" or the "Company") today announced its third quarter 2024 ("Q3 2024") operational ...

Intchains Group Limited (Nasdaq: ICG) ("we," or the "Company"), an innovative altcoins development company that primarily focuses on providing integrated ...

On November 21, 2024, Primega Group Holdings Limited (Nasdaq: PGHL) (the "Company"), was notified by Nasdaq Listing Qualifications Staff of the Nasdaq Stock ...

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) ("Foresight" or the "Company"), an innovator in automotive vision systems, today reported ...

Rakovina Therapeutics Inc. (TSX-V: RKV, the "Company") a biopharmaceutical company committed to advancing new cancer therapies based on ...

YTD EBITDA increased to $7.5 million; a twenty-fold improvement compared to 2023-YTD EBITDA of $0.4 million2024-YTD Adjusted EBITDA increased 260% to $9.6 million compared to 2023-YTD of $3.7 millionF ...

PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that ...

Q3 Revenue improves 3.5% Year-over-Year to $26.1 million Delivers $7.5 million in Adjusted EBITDA, representing 29% margin Generates $9.6 million in Positive ...